IR Biosciences Holdings, Inc. Share Price
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Sales 2009 | - | Sales 2010 | - | Capitalization | 1.2M 94.35M |
---|---|---|---|---|---|
Net income 2009 | -6M -473M | Net income 2010 | -5M -395M | EV / Sales 2009 | - |
Net Debt 2009 | 5.81M 458M | Net Debt 2010 | 3.67M 289M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.37
x | P/E ratio 2010 |
-0.2
x | Employees | 4 |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/06/03 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 30/11/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/06/03 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 17 | |
+28.80% | 49.18B | |
+1.02% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.72% | 26.09B | |
-22.16% | 18.71B | |
+7.91% | 13.26B | |
+32.48% | 12.32B | |
-0.75% | 11.99B |
- Stock Market
- Equities
- IRBS Stock